In this trial, we are evaluating the safety and tolerability of an experimental new medicine. The medicine is an injection being developed to prevent tetanus. This injection is a human monoclonal antibody against tetanus toxin. Monoclonal antibodies are a type of protein or antibody that is produced by a single clone of cells, these antibodies or proteins will only bind to one substance or foreign body. The study drug or a placebo will be administered as an intramuscular (into the muscle) injection.
Recruitment for this study is now complete. Thank you to everyone who has participated.